Stress Reduction Through Acupuncture
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Aug 12, 2025
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether acupuncture can help reduce feelings of stress and emotional distress in women who have recently finished treatment for breast cancer. The study will compare women who receive acupuncture once a week for eight weeks to those who wait for treatment, to see if acupuncture makes a difference in how they feel emotionally after their cancer therapy.
Women who might join this study are those who have completed their main breast cancer treatments—like surgery, chemotherapy, or radiation—within the past six months and who are feeling moderately to highly stressed (measured by a simple distress scale). Participants need to be adults, able to understand and agree to take part, and not pregnant. During the study, women will receive weekly acupuncture sessions, which are gentle treatments using thin needles placed in specific spots on the body. The study is not yet recruiting, but if you qualify, you can expect to be part of a supportive research program exploring ways to improve emotional well-being after breast cancer treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion criteria:
- • Patients with localized breast cancer having completed primary therapy (operation +/- chemotherapy +/- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial
- • Prior cancer is allowed
- • Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed
- • Concomitant participation in an experimental therapeutic drug trial is allowed
- • Ongoing or planned Anti-her2/neu, immune checkpoint inhibitor, antihormonal and CDK4/6 inhibitor therapy or other adjuvant treatment scheduled for \> 3 months during study period is allowed
- • Use of other complementary methods (including mistletoe) is allowed.
- Exclusion criteria:
- • Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study
- • Severe physical or psychiatric comorbidity that prevents a patient from participating in the study
- • Patients incapable of giving consent
- • Pregnancy
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, Switzerland
Patients applied
Trial Officials
Viola Heinzelmann-Schwarz, Prof.MD
Study Chair
University Hospital of Basel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported